Skip to main content
. 2025 Jul 28;25:371. doi: 10.1186/s12905-025-03796-y

Table 6.

Clinical characteristics of previously reported cases of lamotrigine-induced TEN

Study Age/sex Lamotrigine Dosage Onset (Days) Mucosal
Involvement
Treatment Outcome

Sullivan JR et al.

[37],

1996

29/F

25 mg

alternate nights

9 Oral, genital Cyclosporine (4.5 mg/kg/d) Cured

Fernández CalvoC et al.

[38], 2000

44/F N/A 42 N/A GC Cured

Tristani-FirouziP

et al.

[39],

2002

14/F N/A N/A N/A IVIG Cured

Sladden M et al.

[40],

2004

26/F

25 mg

alternate days

14 Oral, genital Supportive therapy Cured

ChangCC et al.

[41],

2005

32/F 12.5 mg/d 14 N/A MP Cured

Rodríguez-BlancoI

et al.

[42],

2005

37/M 50 mg/d 3 N/A PD Cured

VargheeSP et al.

[43],

2006

14/F 25 mg/d 21 N/A MP Cured
28/F 25 mg/d 18 N/A MP Cured
14/F 50 mg/d 21 N/A MP Cured

DuparA

et al.

[44],

2010

16/F N/A 15 oral N/A Cured

Fayaz A

et al. [45],

2011

20/F 200 mg/d 18 Oral Intravenous dexamethasone for 3 days Cured

Kazeem

et al. [26],

2009

37/F

12.5 mg/d

With valproic acid1050 mg

21 Oral, ocular steroid hormone 1000 mg/d Died

Kazee

et al.

[26],

2009

19/F 100 mg/d 14 Oral, ocular

0.5 mg/kg/d

of IgM-IVIG

Cured

HaoxiangX et al.

[46],

2009

72/F 75 mg/d N/A N/A IVIG + MP Cured

HaoxiangX et al.

[46],

2009

35/F 50 mg/d 10 N/A Corticosteroids Cured

HuangHT et al.

[47],

2010

30/M 30 mg/d 19 N/A Antibiotics Cured

BarvaliyaMJ et al. [48],

2012

12/M 50 mg/d 28 N/A Steroids Died

KaurSKad DograA

[49],

2013

47/F 100 mg/d 12 N/A PD Cured
26/F N/A 28 N/A PD Uneventful Recovery

Russomanno

et al.

[50],

2021

22/F N/A 14 Oral, ocular Cyclosporine×5d Cured

Lindsey J et al.

[51],

2022

29/F Lamotrigine (L) and TMP-SMX 17

Oral, ocular, esophagel,

genital

Cyclosporine×14 d Cured
Current case 33/F Lamotrigine 25 mg/d, oxcarbazepine 75 mg/d and topiramate 100 mg/d 9 Oral, ocular dexamethasone combined with IVIG etc. Cured

Abbreviations: TEN: Toxic Epidermal Necrolysis; F: female; M: male; d: day; GC: glucocorticoid; IVIG: intravenous immunoglobulin; NOS: not otherwise specified; N/A: not applicable; TMP-SMX: trimethoprim-sulfamethoxazole; PD: prednisone; MP: methylprednisolone; Onset: Time from Drug Exposure to Rash Onset